Jazz Pharmaceuticals Plc (JAZZ)
254.47
+0.19
(+0.07%)
USD |
NASDAQ |
Aug 24, 16:00
253.57
-0.90
(-0.35%)
After-Hours: 06:47
Jazz Pharmaceuticals Net Income (Quarterly) : 192.80M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 192.80M |
| March 31, 2026 | 293.10M |
| December 31, 2025 | 203.45M |
| September 30, 2025 | 251.41M |
| June 30, 2025 | -718.47M |
| March 31, 2025 | -92.54M |
| December 31, 2024 | 191.12M |
| September 30, 2024 | 215.06M |
| June 30, 2024 | 168.57M |
| March 31, 2024 | -14.62M |
| December 31, 2023 | 94.15M |
| September 30, 2023 | 146.82M |
| June 30, 2023 | 104.44M |
| March 31, 2023 | 69.42M |
| December 31, 2022 | -240.72M |
| September 30, 2022 | -19.65M |
| June 30, 2022 | 34.66M |
| March 31, 2022 | 1.647M |
| December 31, 2021 | -35.35M |
| September 30, 2021 | -52.83M |
| June 30, 2021 | -363.32M |
| March 31, 2021 | 121.83M |
| December 31, 2020 | 133.41M |
| September 30, 2020 | 148.23M |
| June 30, 2020 | 114.80M |
| Date | Value |
|---|---|
| March 31, 2020 | -157.83M |
| December 31, 2019 | 73.99M |
| September 30, 2019 | 102.28M |
| June 30, 2019 | 261.90M |
| March 31, 2019 | 85.20M |
| December 31, 2018 | 159.47M |
| September 30, 2018 | 149.32M |
| June 30, 2018 | 92.32M |
| March 31, 2018 | 45.99M |
| December 31, 2017 | 232.21M |
| September 30, 2017 | 63.53M |
| June 30, 2017 | 105.60M |
| March 31, 2017 | 86.51M |
| December 31, 2016 | 116.69M |
| September 30, 2016 | 89.83M |
| June 30, 2016 | 114.50M |
| March 31, 2016 | 75.81M |
| December 31, 2015 | 82.76M |
| September 30, 2015 | 87.96M |
| June 30, 2015 | 88.11M |
| March 31, 2015 | 70.70M |
| December 31, 2014 | 81.61M |
| September 30, 2014 | 25.77M |
| June 30, 2014 | 43.59M |
| March 31, 2014 | -93.64M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Avadel Pharmaceuticals Plc | 0.02M |
| Perrigo Co. Plc | 88.50M |
| GH Research Plc | -15.15M |
| Cosmo NV | -- |
| Liquidia Corp. | 74.72M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 1.208B |
| Total Expenses (Quarterly) | 1.016B |
| EPS Diluted (Quarterly) | 2.778 |
| Enterprise Value | 18.70B |
| Gross Profit Margin (Quarterly) | 76.30% |
| Profit Margin (Quarterly) | 15.96% |
| Earnings Yield | 5.70% |
| Operating Earnings Yield | 5.76% |
| Normalized Earnings Yield | 6.547 |